Viatris (VTRS) EBIT (2019 - 2026)
Viatris' (VTRS) quarterly EBIT came in at -$79.7 million in Q1 2026, up 97.23% year-on-year from -$40.4 million in Q1 2025, and up 58.64% quarter-over-quarter from -$192.7 million in Q4 2025.
Viatris (VTRS) EBIT (2019 - 2026) Analysis & Trends
Viatris' EBIT history runs 8 years deep, the most recent figure standing at -$79.7 million for Q1 2026.
- On a quarterly basis, EBIT rose 97.23% year-over-year to -$79.7 million in Q1 2026; TTM through Mar 2026 was $139.4 million, a 104.53% increase from a year earlier, with the FY2025 full-year figure at -$2.7 billion, down 26467.33% from the prior year.
- EBIT rose to -$79.7 million in Q1 2026 per VTRS's latest filing, from -$192.7 million in the prior quarter.
- Across five years, EBIT topped out at $707.4 million in Q1 2022 and bottomed at -$2.9 billion in Q1 2025.
- The 5-year median for EBIT is $203.9 million (2024), against an average of -$20.7 million.
- Across the five-year window, EBIT jumped 1247.91% in 2022 and plunged 1513.54% in 2025, its largest moves.
- Year by year, EBIT stood at -$201.3 million in 2022, then tumbled by 125.78% to -$454.5 million in 2023, then surged by 60.44% to -$179.8 million in 2024, then dropped by 7.17% to -$192.7 million in 2025, then surged by 58.64% to -$79.7 million in 2026.
- Per Business Quant, the three latest VTRS EBIT figures stand at -$79.7 million (Q1 2026), -$192.7 million (Q4 2025), and $178.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 325.80 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 291.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 9.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -79.70 Mn |
| Dec 31, 2025 | -192.70 Mn |
| Sep 30, 2025 | 178.80 Mn |
| Jun 30, 2025 | 233.00 Mn |
| Mar 31, 2025 | -2.88 Bn |
| Dec 31, 2024 | -179.80 Mn |
| Sep 30, 2024 | 225.90 Mn |
| Jun 30, 2024 | -239.90 Mn |
| Mar 31, 2024 | 203.90 Mn |
| Dec 31, 2023 | -454.50 Mn |
| Sep 30, 2023 | 451.70 Mn |
| Jun 30, 2023 | 369.20 Mn |
| Mar 31, 2023 | 399.80 Mn |
| Dec 31, 2022 | -201.30 Mn |
| Sep 30, 2022 | 560.10 Mn |
| Jun 30, 2022 | 548.70 Mn |
| Mar 31, 2022 | 707.40 Mn |
| Dec 31, 2021 | -77.60 Mn |
| Sep 30, 2021 | 357.60 Mn |
| Jun 30, 2021 | -47.80 Mn |